- Lion's tooth
- Pu gong ying
- Swine snout
- Wild endive
For Patients & Caregivers
Dandelion has not been shown to treat or prevent cancer.
Dandelion is used in traditional medicine to treat many ailments. Laboratory studies have shown that dandelion can kill certain bacteria and other microbes. It was also found to have anticancer properties in various cancer cells, but studies have not been conducted in humans. Dandelion has estrogenic activity and therefore may increase the growth of hormone-sensitive cancer cells. Dandelion can also promote urination.
- To treat cancer
Laboratory studies have shown dandelion to have anticancer properties, but clinical studies have not shown this effect in humans.
- To treat diabetes
Laboratory studies have shown dandelion to lower blood sugar, however no clinical studies have evaluated its effects in diabetic humans.
- To stimulate lactation
Dandelion is used in Chinese medicine to promote lactation. Scientific evidence to support this use is lacking.
- To treat jaundice and other liver diseases
There are no studies to evaluate this use.
- To promote urination
Extracts of dandelion may increase the frequency of urination.
- You are taking lithium: Dandelion may increase sodium depletion.
- You are taking diuretic drugs: Dandelion may increase diuretic effects.
- You are taking hypoglycemic drugs: Theoretically, dandelion may lower blood sugar levels.
- You are taking Cytochrome P450 (CYP) substrate drugs: Dandelion inhibits CYP3A4 activities and may result in changes in blood levels of substrate drugs.
- You have hormone-sensitive cancers: Dandelion may increase the growth of these cancer cells.
- You have chronic kidney disease: Dandelion tea contains high level of oxalates which can accumulate in patients with compromised kidney function leading to toxicity.
- Stomach inflammation
- Mild diarrhea
- Low blood sugar
- Bladder inflammation: In a 33-year-old woman who used a slimming product containing dandelion. Symptoms resolved after product discontinuation.
- Gangrene of the fingers: In a 56-year-old man with chronic kidney disease after intake of large quantities of dandelion tea due to accumulation of oxalates.
- Rare allergic reactions: Including red, itchy bumps; children may be more prone to allergies with dandelion.
- Toxic blood levels of immune suppressant drugs: In a kidney transplant recipient, that occurred after consumption of a tea that contained dandelion, which inhibits an enzyme used in the metabolism of these drugs.
For Healthcare Professionals
Dandelion is related to the daisy family and commonly found worldwide. The flower, leaf and root of this plant are used in traditional medicine for their diuretic, cholagogic, antirheumatic and appetite-stimulating properties (23). In Chinese Medicine, the herb has been used to promote lactation and reduce abscesses, especially in the breast and intestines (2).
In vitro and in vivo studies suggest that dandelion has lipid-lowering (13), hepatoprotective (14), and antiviral (15) (16) properties. It also has anticoagulant (5), diuretic (10), anti-inflammatory (14), and antioxidant (4) activities. Dandelion root extract has anticancer effects against melanoma (3) and leukemia (8) (26), as well as pancreatic (17) and colorectal (25) cancer cell lines. However, human studies are limited.
Dandelion has estrogenic activity. It may increase the proliferation of hormone-sensitive breast cancer cells (24). It can also cause allergic reactions and may interact with some prescription drugs.
The diuretic activity of dandelion may be a result of its high potassium content (23). In murine models of diet-induced fatty liver disease, dandelion leaf extract exihibited hepatoprotective effects with decreased serum levels of ALT, hepatic TG, and MDA, as well as TNF-alpha and IL-6 expression (14). At the post-transcriptional level, antioxidant and anti-inflammatory properties were exihibited via decreased activation of procaspase-3 to active caspase-3, and JNK phosphorylation (14). Linoleic acid, phytol and tetracosanol have been identified as bioactive compounds, with hypolipidemic effects occurring via AMP-activated protein kinase activation in human HepG2 cells (13).
Dandelion has been shown to decrease human hepatoma cell line viability by increasing tumor necrosis factor-alpha and interleukin-1alpha production (9). Other research has shown that the presence of luteolin and luteolin 7-glucoside in dandelion flower extract exhibits cytotoxic activities against the colon adenocarcinoma cell line (Caco-2) (4). An isolated compound identical to lupeol, a lupane-type triterpene, inhibited cell growth and induced melanogenesis in a mouse melanoma cell line (3). Taraxinic acid, derived from dandelion, induced differentiation in a promyelocytic leukemia cell line (8).
Sesquiterpene lactones are thought to be the allergenic compounds in dandelion (7).
Hemorrhagic cystitis: In a 33-year-old woman following use of a slimming product containing dandelion. Symptoms resolved after product discontinuation (12).
Toxic blood levels of immunosuppressive agents: In a kidney transplant recipient, that occurred after consumption of a tea that contained dandelion, which inhibits CYP3A4 used in the metabolism of these drugs (19) (20).
Digital necrosis: In a 56-year-old man with chronic kidney disease, cutaneous manifestations of hyperoxaluria related to high intake of dandelion tea (10–15 cups daily for 6 months) (21).
Contact dermatitis: In a 7-year-old boy, which improved by avoidance of handling plants (7).
- Diuretics: Dandelion may have additive effects due to its diuretic activity (10) (23).
- Hypoglycemics: Dandelion may have additive effects due to its hypoglycemic property (23).
- Cytochrome P450 (CYP) 1A2, 3A4 substrates: Dandelion inhibits CYP1A2 (28), CYP3A4 activities (19) (20) and may result in changes in blood levels of substrate drugs.
- UDP-glucuronosyl transferase (UGT) substrates: Dandelion induces UGT activity (28) and may increase blood levels of substrate drugs.